[Local treatments using antiviral and non-antiviral drugs for herpes facialis and genitalis (excluding pregnant females and neonates at risk)].
Chosidow
O
O
Service de Médecine Interne, Groupe Hospitalier Pitie-Salpetriere, Paris, France.
Lebrun-Vignes
B
B
D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000287:Administration, Topical; D000975:Antioxidants / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D002084:Butylated Hydroxytoluene / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006147:Guanine; D006558:Herpes Genitalis / Q000188:drug therapy*; D006560:Herpes Labialis / Q000188:drug therapy*; D018259:Herpesvirus 1, Human; D018258:Herpesvirus 2, Human; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use
D000975:Antioxidants; D000998:Antiviral Agents; D016898:Interferon-alpha; D002084:Butylated Hydroxytoluene; C053539:penciclovir; D006147:Guanine; D014740:Vidarabine; D000212:Acyclovir